International study led by Massey researcher finds promise in new class of anti-cancer drugs
A new class of platinum-based drugs has shown significant anti-metastatic effects in fighting cancer, according to a recently published study led by a Virginia Commonwealth University chemistry professor and Massey researcher.
Massey researcher finds better risk management of opioid abuse needed among cancer patients
Opioid addiction is an epidemic in the U.S. and other developed nations, and cancer patients are at even greater risk. Opioids are commonly prescribed to control cancer pain, and VCU Massey Cancer Center Palliative Care Director Egidio Del Fabbro, M.D., says more should be done to identify the potential for abuse and addiction among cancer patients.
How an aquarium pet became a scientific star in childhood cancer research
Seth Corey, M.D., M.P.H., joined VCU Massey Cancer Center and Children’s Hospital of Richmond at VCU (CHoR) in October 2015 as the chief of the Division of Hematology, Oncology, and Stem Cell Transplantation in the Department of Pediatrics. He is also the inaugural Children’s Hospital Foundation Endowed Chair in Pediatric Cancer Research, which is funded by a large grant from Children’s Hospital Foundation and a gift from Connor’s Heroes. Additionally, he is the co-leader of Massey’s Cancer Molecular Genetics research program and a professor of pediatrics and microbiology/immunology at the VCU School of Medicine. A board-certified pediatric oncologist and cancer researcher, Corey specializes in leukemias, bone marrow failure, and stem cell transplantation.
Massey researcher awarded $3 million to study the effect of blood cell stimulation on the development of adolescent leukemia and bone marrow disorders
Massey program leader, researcher and physician Seth Corey M.D., M.P.H., was awarded more than $3 million in grant funding from the National Heart, Lung and Blood Institute (NHLBI) for a four-and-a-half-year study on the evolution of a blood cell deficiency to pre-leukemia. The research aims to determine whether a common treatment for the condition acts as a contributor to the development of leukemia or other life-threatening bone marrow disorders.
VCU Massey researchers uncover process that drives prostate cancer metastasis
Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps prostate cancer cells metastasize (spread) to other parts of the body. This mechanism highlights new potential targets for cancer therapies and challenges the previous understanding of PLK1’s role in cancer growth and progression.